Tetrasubstituted pyridazines hedgehog pathway antagonists

Details for Australian Patent Application No. 2009314288 (hide)

Owner Eli Lilly and Company

Inventors Clay, Julia Marie; Hipskind, Philip Arthur; Sall, Daniel Jon; Wilson (Nee Takakuwa), Takako; Thompson, Michelle Lee; Bastian, Jolie Anne

Agent Spruson & Ferguson

Pub. Number AU-A-2009314288

PCT Pub. Number WO2010/056620

Priority 61/115,362 17.11.08 US

Filing date 9 November 2009

Wipo publication date 20 May 2010

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/056620 Priority application(s): WO2010/056620

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314299-Inhibitors of fatty acid binding protein (FABP)

2009314273-Method and tool for determination of fracture geometry in subterranean formations based on in-situ neutron activation analysis